// App-Quantinova.ai

: Effect of decipher test on adjuvant treatment decision-making among men with high-risk pathology at radical prostatectomy: Results from a multicenter prospective PRO-IMPACT study.

Researchers

Presenter

  • John L. Gore

Principal Investigators

  • Maria Santiago-Jimenez

  • Kasra Yousefi

  • Darby Thompson

  • David Chen

  • William Clark

  • Michael Franks

  • Lawrence Ivan Karsh

  • Adam S. Kibel

  • Hyung Lae Kim

  • Brian R. Lane

  • Yair Lotan

  • William Thomas Lowrance

  • Paul Maroni

  • Scott David Perrapato

  • Edouard John Trabulsi

  • Robert J. Waterhouse

  • Elai Davicioni

  • Daniel W. Lin

Medical Centers

  • University of Washington School of Medicine, Seattle, WA

  • GenomeDx Biosciences Inc., Vancouver, BC, Canada

  • EMMES Canada, Burnaby, BC, Canada

  • Fox Chase Cancer Center, Philadelphia, PA

  • Alaska Clinical Research Center, Anchorage, AK

  • Virginia Urology, Richmond, VA

  • The Urology Center of Colorado, Denver, CO

  • Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • Spectrum Health Hospital System, Grand Rapids, MI

  • UTSouthwestern Medical Center, Dallas, TX

  • Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT

  • University of Colorado, Denver Medical Campus, Denver, CO

  • University of Vermont Medical Center, Burlington, VT

  • Thomas Jefferson University, Philadelphia, PA

  • Carolina Urology Partners, Gastonia, NC

  • University of Washington, Seattle, WA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • NCT02080689

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved